Companies / Nektar Therapeutics

Nektar Therapeutics

Nasdaq: NKTRCIK 906709SAN FRANCISCO, CAnektar.com ↗
Insider flow · last 90 daysNet sells $1.24M

Financials · FY2025

Revenue$55.23M
Net income$-164.08M
Total debt$133.50M
Cash$149.58M
Diluted EPS$-9.73
Shares outstanding33.8M

Ownership

33.8M shares outstanding · as of May 1, 2026
0.23%Insiders
Ownership
Insiders0.23%76,219
10%+ / strategic8.99%3,036,761
Institutions68.05%22,992,796
Public float22.73%7,680,256

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 3

View all →
Insider% of sharesShares
Robin Howard WCEOPresident & CEO · Director
0.16%55,045
Zalevsky JonathanChief R&D Officer
0.06%21,174
Rubinstein Linda MInterim CFO
——

Institutional holders 190

View all →
HolderValue% of shares
BlackRock, Inc.$205.37M8.71%
Bvf INC/IL$184.16M7.58%
Two Sigma Investments, LP$66.97M2.75%
State Street Corporation$63.50M2.69%
Farallon Capital Management LLC$45.01M2.34%
Vanguard Group Inc$43.43M3.04%
Two Seas Capital LP$31.51M2.21%
Millennium Management LLC$29.09M1.20%
Emerald Advisers, LLC$28.39M1.17%
Armistice Capital, LLC$25.20M1.76%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Jun 17, 2026Robin Howard W
CEO
SellCommon Stock$334.5K-6K
-8.46%
59,545
0.18% of shares
medium
Jun 16, 2026Robin Howard W
CEO
SellCommon Stock$318.0K-5K
-7.07%
69,742
0.21% of shares
medium
Jun 16, 2026Robin Howard W
CEO
SellCommon Stock$285.2K-5K
-6.73%
65,045
0.19% of shares
medium
Jun 17, 2026Robin Howard W
CEO
SellCommon Stock$277.4K-5K
-7.56%
55,045
0.16% of shares
medium
Jan 20, 2026Zalevsky Jonathan
Executive
SellCommon Stock$137.9K-4K
-15.33%
21,354
0.06% of shares
medium
Feb 18, 2026Robin Howard W
CEO
SellCommon Stock$30.9K-423
-0.56%
75,489
0.22% of shares
low
May 19, 2026Robin Howard W
CEO
SellCommon Stock$29.1K-444
-0.59%
75,045
0.22% of shares
low
Feb 18, 2026Zalevsky Jonathan
Executive
SellCommon Stock$13.1K-180
-0.84%
21,174
0.06% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Vanguard Group IncPassive13G/A—0—
Vanguard Group IncPassive13G—1,027,089—
Capital Ventures InternationalPassive13G/A———
Fmr LLCPassive13G—3,036,761—

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
NKTR——640268306—